logo
HEALWELL Provides Corporate Update Including Improved Performance in AI Business, Acquisition of Remaining Interest in Pentavere and Deeper Integration within the AI Business Segment

HEALWELL Provides Corporate Update Including Improved Performance in AI Business, Acquisition of Remaining Interest in Pentavere and Deeper Integration within the AI Business Segment

Globe and Mail16-07-2025
HEALWELL announced improved performance for its core AI business segment with preliminary revenues expected to exceed $5 million for the first six months of 2025, reflecting a year-over-year increase of over 200% as compared to the same period last year. This strong performance is expected to lead to positive Adjusted EBITDA for the AI business segment during the first six months of the year.
HEALWELL acquires remaining 49% of Pentavere Research Group Inc., by exercising a call option to gain full ownership of the business. Pentavere is an award winning and globally renowned AI healthcare company which is responsible for the development of a leading AI-driven patient identification platform, DARWEN. TM
With 100% ownership of Pentavere, HEALWELL intends to deepen integration between its AI businesses and accelerate commercialization of AI products across healthcare offerings.
Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (" HEALWELL" or the " Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to provide a corporate update, including improved performance in its AI business units, the acquisition of the remaining interest in Pentavere Research Group Inc. (" Pentavere") and deeper integration of the entities within its AI business segment.
The Company's AI business segment, encompassing Pentavere, Khure Health ("Khure"), and Mutuo Health Solutions ("Mutuo") businesses, is on track to exceed $5 million in revenues for the first six months of 2025, ending June 30, 2025, representing a year-over-year increase of over 200%. This strong performance is expected to lead to positive Adjusted EBITDA for the AI business segment during the same period.
Strategic Acquisition and Performance Highlights
Full Ownership of Pentavere: HEALWELL has exercised its call option to acquire the remaining 49% of Pentavere, gaining full ownership of the globally recognized AI healthcare company. Pentavere is the developer of DARWEN™, a leading AI-driven patient identification platform crucial for preventative care.
Robust Organic Growth: Preliminary results for Q2-2025 show significant organic revenue growth within the AI segment, with both Pentavere and Khure each increasing by more than 100% during the first six months of 2025 compared to the same period last year. This demonstrates the Company's enhanced connectivity with the life sciences marketplace.
New Leadership and Forward Strategy
James Lee, HEALWELL's new Chief Executive Officer, effective July 1, 2025, commented, "I'm incredibly pleased with the strong performance of our core AI division, and I believe its potential is substantial. With Orion Health now part of our family and 100% ownership of Pentavere, we have a unique opportunity to truly differentiate our offering and accelerate the commercialization of our AI products. We are already seeing strong interest in our various AI products, from some of the largest healthcare systems in the world."
HEALWELL's strategy is to deeply integrate its AI and data science products into its software platforms. This approach provides a direct path to market, leveraging existing customer bases and contracts to enable healthcare systems worldwide to adopt AI solutions more readily.
Hamed Shahbazi, HEALWELL's Chairman, emphasized the significance of Pentavere, "DARWEN™ is a globally unique and recognized AI solution, validated by some of the largest and most complex healthcare systems. Its focus on ethical and compliant training with permissioned data, alongside clinical validation in over 40 publications, positions it to lead the healthcare sector in deploying AI insights for real-world outcomes. We also continue to be greatly impressed with both the capability and thought leadership of the Pentavere team and are excited to watch them continue their efforts to modernize and AI-enable preventative health."
Commitment to Preventative Care
Mr. Lee further commented on the urgent need for AI in healthcare, "Global healthcare systems face relentless demands amid budgetary and staffing challenges. AI-based tools like Pentavere's DARWEN™ are breaking new frontiers in patient identification and preventative care, holding the potential to save and protect many lives. Our role is to be an enabler of preventative care, and we must act with urgency. We are committed to delivering on our vision, and along with the Company's President, Dr. Alexander Dobranowski, I look forward to sharing key milestones as we achieve them."
Transaction Details of Pentavere Call Option Exercise
HEALWELL has acquired the remaining 49% of Pentavere which it did not already own by exercising a call option that it had previously negotiated at the time of its original acquisition of a majority interest in Pentavere in 2023 (the " Call Option"). Pursuant to the Call Option, HEALWELL has acquired all of the remaining issued and outstanding shares of Pentavere for an aggregate purchase price of $13,978,244.70, which was satisfied with the issuance of 10,161,562 Subordinate Voting Shares at a deemed price of $1.3756 per share, equal to the 5-Day VWAP on July 11 th, 2025.
James Lee
Chief Executive Officer
HEALWELL AI Inc.
Footnotes:
"Adjusted EBITDA" is a non-IFRS financial measure and may not be comparable to other similar measures disclosed by other companies. For more information on the composition of this measure, its purpose and a reconciliation to the nearest IFRS measures, please see " Non-IFRS Financial Measures" in the Company's most recent MD&A dated May 12, 2025, a copy of which is available under the Company's profile on SEDAR+ at www.sedarplus.ca.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
Forward-Looking Statements
Certain statements in this press release, constitute "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws, including statements about the Company's strategic plan and expected timelines, milestones and future announcements under the plan; and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as "mission", "intends", "to be", "coming", "opportunities", "look forward to", "expected" or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward-looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: HEALWELL's ability to integrate its AI technologies into its other service offerings and platforms; HEALWELL's ability to maintain and leverage its relationships with their commercial partners; the continued adoption of the software, tools and solutions created by HEALWELL and its subsidiaries; that HEALWELL will be successful in identifying, executing and integrating new acquisitions, investments and/or partnerships; the stability of general economic and market conditions; sufficiency of working capital and access to financing; HEALWELL's ability to comply with applicable laws and regulations; HEALWELL's continued compliance with third party intellectual property rights; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; technologies working as intended or at all; trends in customer growth and the adoption of new technologies in the industry; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.
Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in HEALWELL's most recent annual information form dated March 31, 2025, which is available under HEALWELL's SEDAR+ profile at www.sedarplus.ca. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
This news release contains future-oriented financial information and financial outlook information (collectively, "FOFI") about the expected Q2 2025 revenue and Adjusted EBITDA generated by the Company's AI business, which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraphs. The actual financial results of the Company's AI business segment may vary from the amounts set out herein and such variation may be material. HEALWELL and its management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, HEALWELL undertakes no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about HEALWELL's anticipated future business operations and strategic plan for the coming year. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Imagen Network Integrates Grok Framework to Enhance Feed Logic and Adaptive User Experience
Imagen Network Integrates Grok Framework to Enhance Feed Logic and Adaptive User Experience

Globe and Mail

time2 hours ago

  • Globe and Mail

Imagen Network Integrates Grok Framework to Enhance Feed Logic and Adaptive User Experience

Grok-powered enhancements boost AI social curation and personalize decentralized peer interactions. Singapore, Singapore--(Newsfile Corp. - July 29, 2025) - Imagen Network (IMAGE), the decentralized AI social platform, has integrated the Grok framework to expand its adaptive feed logic and user experience personalization tools. The move empowers real-time adjustments to user feeds based on behavior patterns, interests, and social engagement data. Powering dynamic social feeds with intelligent, decentralized personalization. To view an enhanced version of this graphic, please visit: Grok's intelligent routing and inference capabilities enhance Imagen's curation engine—allowing AI systems to filter, prioritize, and surface content more accurately. This ensures that user feeds evolve dynamically, offering each participant a unique, context—aware social experience while preserving privacy and sovereignty. Combined with Imagen's decentralized content governance and token-based engagement mechanics, this integration represents a leap forward in scalable AI moderation for social applications. Peer-to-peer curation is faster, more intuitive, and better aligned with user intent and values. The Grok-backed enhancements support Imagen's broader mission: to give individuals creative control, better discovery, and real-time relevance in a decentralized digital world. About Imagen Network Imagen Network is a decentralized social platform that blends AI content generation with blockchain infrastructure to give users creative control and data ownership. Through tools like adaptive filters and tokenized engagement, Imagen fosters a new paradigm of secure, expressive, and community-driven networking. Media Contact Dorothy Marley KaJ Labs +1 707-622-6168 media@ Social Media Twitter Instagram

WAIC 2025: Shanghai Electric Debuts First Industrial Humanoid Robot "SUYUAN," Advancing Next-Gen Intelligent Manufacturing through Holistic Value Chain Layout
WAIC 2025: Shanghai Electric Debuts First Industrial Humanoid Robot "SUYUAN," Advancing Next-Gen Intelligent Manufacturing through Holistic Value Chain Layout

Globe and Mail

time2 hours ago

  • Globe and Mail

WAIC 2025: Shanghai Electric Debuts First Industrial Humanoid Robot "SUYUAN," Advancing Next-Gen Intelligent Manufacturing through Holistic Value Chain Layout

SHANGHAI , July 29, 2025 /CNW/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) proudly unveiled its first self-developed industrial humanoid robot, "SUYUAN," during its global debut at the World Artificial Intelligence Conference on July 26 in Shanghai . With 38 degrees of freedom (DoF) and 275 TOPS of on-device computation power, SUYUAN delivers precise operations and dynamic movements, making it adaptable to a wide range of industrial application scenarios. This launch represents a significant milestone in Shanghai Electric's humanoid robotics journey, further strengthening its comprehensive value chain for industrial humanoid solutions. Designed with human-like proportions—standing 167 cm tall and weighing 50 kg—SUYUAN is engineered to navigate complex industrial environments with ease. Its 38-DoF articulation provides exceptional dexterity, enabling both delicate manipulations and expansive motions. Capable of handling up to 10 kg of total cargo and lifting 2 kg objects with a single arm, SUYUAN is perfectly suited for logistics and assembly line tasks, operating efficiently at a movement speed of 5 km/h. SUYUAN leverages a fusion of LiDAR and binocular vision technologies to achieve self-guided mobility. Its 275-TOPS on-device AI processor powers instant data analysis and LLM integration, allowing natural task interpretation and adaptive object handling. In pilot tests, SUYUAN autonomously identified, positioned, picked, and relocated mixed-size crates, using advanced computer vision and synchronized joint control, significantly boosting warehouse productivity. Supercharging the Industrial Revolution: Intelligent Manufacturing Powered by Humanoid Precision The high-end equipment manufacturing advancements driven by innovation hinge on real-world applications. At WAIC 2025, Shanghai Electric's "LINGKE" dual-arm robot also wowed the audiences at a skills showcase, tackling complex manufacturing challenges with its high-precision operation, adaptive collaboration, and closed-loop data capabilities. LINGKE is more than a human labor replacement. It uses bimanual coordination and compliant force control to free workers from repetitive, high-intensity tasks, improving efficiency fivefold. The core competency lies in its Data-Model-Deployment closed-loop technology. With operational data as the starting point, LINGKE creates self-optimizing workflow through data cleansing and annotation, model training, live deployment, and feedback-based optimization, achieving the transition from "passive executors" to "active learners." Pioneering Smarter Automation At WAIC 2025, a joint venture between Shanghai Electric and Johnson Electric debuted with a showcase of revolutionary humanoid robots, key hardware modules, and system integration solutions. The venture introduced rotary joints, linear joints, and dexterous finger joints for next-gen robots, delivering precise, smooth, quiet, and intelligent motion performance. The joint venture further strengthened its efforts to expand product applications by securing two major partnerships: a first-unit supply agreement with the National and Local Co-Built Humanoid Robotics Innovation Center ( Qinglong Project ) and a product cooperation memorandum with Fourier Robotics. With 189 patent applications (including 120 granted) in humanoid robotics, Shanghai Electric is making significant strides in AI-driven industrial innovation. Going forward, Shanghai Electric will expand smart "human-machine" and "inter-machine" collaborative solutions across multifunctional industrial environments. Its comprehensive R&D capabilities—spanning critical components to fully functional robots—are accelerating the development of a world-class AI ecosystem. For more information, please visit

Can virtual care services solve the health-care staffing crisis in rural B.C.?
Can virtual care services solve the health-care staffing crisis in rural B.C.?

CBC

time3 hours ago

  • CBC

Can virtual care services solve the health-care staffing crisis in rural B.C.?

On Monday, a peer-reviewed study found that an initiative called the Real-Time Virtual Support network helped improve access to health care in rural B.C. Lead author Kendall Ho, a professor at the University of B.C.'s department of emergency medicine, said it was important to pair virtual care with an increase in in-person health facilities. Dr. Gavin Parker, president of the Society of Rural Physicians of Canada, argues that while virtual care programs are beneficial, there are also opportunities to increase funding to rural communities.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store